Exploring Teucrium Aureo-Candidum Essential Oil as a Promising Alternative to Triclosan for Targeting Enoyl-Acyl Carrier Protein Reductase: Chemical Composition, Antibacterial Activity, and Molecular Docking Study
- PMID: 39419757
- DOI: 10.1002/cbdv.202401945
Exploring Teucrium Aureo-Candidum Essential Oil as a Promising Alternative to Triclosan for Targeting Enoyl-Acyl Carrier Protein Reductase: Chemical Composition, Antibacterial Activity, and Molecular Docking Study
Abstract
The chemical composition of the essential oil isolated from the aerial parts of Teucrium aureo-candidum, an endemic aromatic shrub collected from Moghrar and Djeniene Bourezg in the Nâama region (Algeria), was determined for the first time using GC/FID and GC/MS. A total of 45 constituents were identified, representing 87.73 % of the oil. Characterized by unique chemical variability, it was primarily composed of sesquiterpene hydrocarbons (29.53 %) and oxygenated sesquiterpenes (30.06 %), with the major compounds being γ-cadinene (5.24 %), δ-cadinene (4.24 %), α-muurolene (4.04 %), τ-muurolol (11.35 %), and α-cadinol (3.30 %). However, monoterpene hydrocarbons and oxygenated monoterpenes accounted for 23.98 % and 1.64 %, respectively, contributing to a relatively low fraction. The essential oil demonstrated notable antibacterial activity, particularly against Gram-positive bacteria. Due to safety concerns associated with triclosan, a known inhibitor of the Enoyl-Acyl Carrier Protein Reductase (FabI) enzyme, the essential oil components from this plant were explored as alternatives through a combination of experimental approaches and in silico molecular docking studies. The results revealed that α-cadinol, spathulenol, caryophyllene, and α-muurolene exhibited strong FabI inhibition, with better bioavailability and lower toxicity than triclosan, highlighting their potential in combating antibiotic-resistant bacteria.
Keywords: Antimicrobial activity; Essential oil; GC/MS; Molecular docking; Teucrium aureo-candidum; Triclosan.
© 2024 Wiley-VHCA AG, Zurich, Switzerland.
References
-
- J. Yao, M. E. Ericson, M. W. Frank, C. O. Rock, Infect. Immun. 2016, 84, 3597–3607, DOI: 10.1128/IAI.00647-16.
-
- J. Schiebel, et al., J. Biol. Chem. 2014, 289, 15987–16005, DOI: 10.1074/jbc.M113.532804.
-
- R. Demissie, P. Kabre, L. W. Fung, ACS Omega 2020, 5, 23175–23183, DOI: 10.1021/acsomega.0c02942.
-
- L. M. Weatherly, J. A. Gosse, J. Toxicol. Environ. Health B Crit. Rev. 2017, 20, 447–469, DOI: 10.1080/10937404.2017.1399306.
-
- Scientific Committee on Consumer Safety (SCCS). Request for a Scientific Advice on the Safety of Triclocarban (CAS No. 101-20-2, EC No. 202-924-1) and Triclosan (CAS No. 3380-34-5, EC No. 222-182-2) as Substances with Potential Endocrine Disrupting Properties Used in Cosmetic Products. Preliminary Version: 15-16 March 2022; Final Version: 24-25 October 2022. Report No. SCCS/1643/22. European Commission, Brussels. Available online: https://health.ec.europa.eu/system/files/2023-08/sccs o 265.pdf.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
